Association between hypertension and immunosuppression in Sars-Cov-2 infection

Vista sencilla de ítem
dc.date.accessioned2023-04-05T12:48:15Z
dc.date.available2023-04-05T12:48:15Z
dc.date.issued2021
dc.description.abstractCoronavirus disease 2019 (COVID-19) has caused more than 32 million cases and almost a million deaths. Recent reviews have evidenced the role of hypertension in prognosis, nevertheless, its association with immunosuppression in COVID-19 context has not been studied. It was performed a cross-sectional analysis of a large Mexican population with the infection (n= 681 890). Prevalence of immunosuppression and hypertension was 1.10% and 19.50%, respectively. The adjusted model evidenced that hypertension was significantly associated with immunosuppression (odds ratio=1.18, 95% CI=1.11-1.25). Further research in pathways that justify the association between hypertension and immunosuppression in COVID-19 patients is recommended. © 2021 by Author/s and Licensed by Modestum.
dc.identifier.issn25163507
dc.identifier.urihttps://doi.org/10.29333/ejgm/10867
dc.identifier.urihttp://146.190.124.33/handle/123456789/6295
dc.language.isoenges_ES
dc.publisherModestum LTDes_ES
dc.sourceInflammation; Vol. 45 Núm. 5
dc.titleAssociation between hypertension and immunosuppression in Sars-Cov-2 infectiones_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.type.versioninfo:eu-repo/semantics/publishedVersion
Archivos
Colecciones
Cartas